Why the study?
Does triclofos enhance warfarin-induced hypoprothrombinemia in volunteers chronically anticoagulated with warfarin?
Does triclofos enhance warfarin-induced hypoprothrombinemia in volunteers chronically anticoagulated with warfarin?
Triclofos significantly potentiates the anticoagulant effect of warfarin by displacing it from human albumin, highlighting a clinically relevant drug-drug interaction.
Answers are grounded in this paper and cite their sources.
Requires close INR monitoring with triclofos initiation in warfarin patients; leaves open randomized confirmation of interaction magnitude.
Daily administration of hypnotic doses of triclofos (trichloroethyl sodium phosphate) significantly prolonged prothrombin time in 7 volunteers chronically anticoagulated with warfarin. Mean sensitivity to warfarin (prothrombin time prolongation/cumulative 72 hour warfarin dose) increased by 49 per cent during the first week of triclofos therapy. Plasma concentrations of factors II and X fell within 9 hours of a single dose of triclofos. A metabolite of triclofos, trichloroacetic acid, accumulated in plasma to 80 µg per milliliter during one week of triclofos administration. The displacement of warfarin from human albumin by trichloroacetic acid can account for the potentiation of warfarin action by triclofos.
No takes yet. Share an insight, caveat, or question.
Sellers et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: